Introduction
The gastrointestinal tract (including the esophagus, stomach, small and large intestine) is a unique organ system in that it has a higher incidence of cancer development and cancer-related mortality than any other system in the body (Parkin et al., 1999) . The human gastrointestinal tract contains 10B100 trillion microorganisms, increasing along the gastrointestinal tract from stomach (B10 . Therefore, the intestinal mucosa plays a crucial role in maintaining barrier function and protecting the host against bacterial invasion while permitting enteric bacteria to aid in nutrient metabolism. Approximately 300B400 m 2 of the gastrointestinal mucosal surface area are in direct contact with potential pathogens and carcinogens. However, our commensal bacteria also help to maintain mucosal homeostasis. For example, germ-free mice demonstrate reduced intestinal epithelial cell proliferation when compared to colonized mice (Nowacki, 1993; Pull et al., 2005) . The lining of the gastrointestinal tract is normally replaced every 2B7 days (Leblond, 1964; Potten et al., 1997; Brittan and Wright, 2002) . Since increased cell turnover is associated with tumorigenesis, an imbalance in epithelial cell proliferation and death in response to the microflora may lead to the higher incidence of malignancies within the gastrointestinal tract.
Epidemiological studies suggest that chronic inflammation plays a significant role in the development of gastrointestinal malignancies. A variety of chronic inflammatory conditions, for example Barrett's esophagus, ulcerative colitis and chronic gastritis caused by H. pylori infection, markedly elevate the risk of developing gastrointestinal malignancies. Therefore, focusing on the relationship between chronic inflammation and carcinogenesis may help to elucidate important mechanisms in the pathogenesis of gastrointestinal malignancies. For example, chronic inflammation caused by H. pylori infection is associated with a higher risk of developing gastric cancer and it is considered a carcinogen (Peek and Blaser, 2002; Houghton and Wang, 2005) . A strong link between inflammation and cancer development is observed in inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis (Itzkowitz and Yio, 2004) . Importantly, the severity of inflammation correlates with the risk of colorectal cancer in patients with IBD (Rutter et al., 2004; Gupta et al., 2007) . In the pathogenesis of IBD, commensal bacteria play a central role in the chronic intestinal inflammation. Initiation and perpetuation of intestinal inflammation has been thought to result from dysregulated immune responses to commensal bacteria in the genetically susceptible host. The genetic polymorphisms predisposing to IBD are at least partly due to an abnormality of innate immune recognition of commensal bacteria.
Therefore, innate immune abnormalities in response to specific or nonspecific luminal bacteria may be responsible for gastrointestinal malignancies induced by chronic gastrointestinal inflammation.
Given the relationship between inflammation and carcinogenesis, investigators have begun to address the role of Toll-like receptors (TLRs) and innate immune responses in inflammation-associated carcinogenesis in the gastrointestinal tract (Huang et al., 2005 (Huang et al., , 2007 Fukata et al., 2007; Xiao et al., 2007) . Although the adaptive immune system prevents tumor growth through immune surveillance, the innate immune system may promote tumor growth through inflammationdependent and -independent mechanisms (Balkwill and Coussens, 2004; de Visser and Coussens, 2005) . In this review, we will discuss the role of innate immune responses, specifically TLR signaling, in the pathogenesis of gastrointestinal malignancies.
TLR signaling in the normal and inflamed gastrointestinal mucosa
TLRs serve important immune and non-immune functions in the human intestine. There are several layers that compose the intestine from stomach to colon. Adjacent to the lumen, and thus the microflora, there is a single layer of intestinal epithelial cells (IEC) that prevent the passage of macromolecules and bacteria. Below this layer, the lamina propria consists of a mixed infiltrate of macrophages, dendritic cells, lymphocytes (primarily immunoglobulin A producing B cells), myofibroblasts and occasional neutrophils. Although, the expression of TLRs in the gastrointestinal tract has been examined, expression, localization and function of individual TLRs remain unclear (Figure 1 ). For example, mucosal expression of TLRs in the esophagus has not yet been elucidated. In the human stomach, TLR2, TLR4, TLR5 and TLR9 are known to be expressed by epithelial cells (Schmausser et al., 2004 (Schmausser et al., , 2005 Baoprasertkul et al., 2007) . The small intestine (including duodenum, jejunum and ileum) and the large intestine express most of the TLRs, but normally TLR signaling in IEC appears to be downregulated (Melmed et al., 2003; Otte et al., 2004; Abreu et al., 2005) . However, altered expression of TLRs in IEC has been reported in the setting of chronic inflammation. Increased expression of TLR4 and MD-2 has been demonstrated in H. pylori-infected gastric epithelial cells from human biopsy specimens and a gastric cancer cell line (Ishihara et al., 2004) . TLR4 is upregulated in IBD, while the expression of TLR2 and TLR5 remains unchanged (Cario and Podolsky, 2000) . Expression of TLR4 and TLR2 is also increased in lamina propria macrophages in IBD (Hausmann et al., 2002) . We and others have demonstrated that inflammatory cytokines such as IFN-g and TNF-a increase expression of TLR4 and MD-2 resulting in increased lipopolysaccharide (LPS) responsiveness in human colonic epithelial cells (Abreu et al., 2001; Suzuki et al., 2003) . Therefore, TLR signaling especially by TLR4 may be increased in the setting of chronic gastrointestinal inflammation.
TLR4 is also important for healing of the injured intestinal epithelium . We and others have described decreased epithelial cell proliferation in TLR4-or MyD88-deficient mice (RakoffNahoum et al., 2004; Fukata et al., 2005 Fukata et al., , 2006 . We have also shown that TLR4-or MyD88-deficient mice have increased epithelial cell apoptosis after mucosal injury caused by dextran sulfate sodium (DSS) treatment (Fukata et al., 2006) . As a mechanism, we have demonstrated that TLR4 signal induces cyclooxygenase-2 (Cox-2) and prostaglandin E 2 (PGE 2 ) in vitro and in vivo (Fukata et al., 2006) . These data suggest a role for MyD88-dependent TLR4 signaling in regulation of IEC proliferation and apoptosis. Pull et al. (2005) have used MyD88À/À mice to create bone marrow chimeras. In response to injury, MyD88-expressing macrophages are required for IEC proliferation (Pull et al., 2005) . In addition, MyD88-dependent signal is suggested to be involved in re-distribution of Cox-2-expressing stromal cells, which can modulate epithelial cell proliferation in response to mucosal injury (Brown et al., 2007) . Because imbalance between epithelial cell proliferation and apoptosis is important for the process of inflammationassociated malignant transformation, TLR signaling via MyD88 may play a pivotal role in the malignant transformation in IEC (Figure 2 ). (Du et al., 2000; Abreu et al., 2001; Melmed et al., 2003; Otte et al., 2004; Rumio et al., 2004; Baoprasertkul et al., 2007) . *Protein expression has been confirmed (Rock et al., 1998; Cario and Podolsky, 2000; Furrie et al., 2005; Schmausser et al., 2005) . In addition to IEC, lamina propria macrophages express TLR4 and TLR2 (Hausmann et al., 2002) , and jejunal smooth muscle cells and myenteric prexus express TLR4 (Rumio et al., 2006) . a Denotes that the receptor has been shown to be functional in response to the appropriate ligand (Naik et al., 2001) . There has been no data of TLR expression in the esophagus at present. TLR, Toll-like receptor.
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Role of TLR signaling in gastrointestinal carcinogenesis
Recognition of bacterial and/or viral products by TLRexpressing cells may induce an inflammatory response associated with tumor promotion (Coussens and Werb, 2002) . Innate immune responses against luminal microbes may result in DNA damage, cell proliferation and modulation of apoptosis. TLR signaling can play diverse roles with respect to tumorigenesis in the intestine. First, TLRs may serve as tumor promoters through its effects on the epithelium. This aspect of TLR signaling will be the principal focus of this review. TLRs may also support tumor growth through complex effects on the microenvironment. For example, concurrent bacterial infection can promote tumor growth in a model of subcutaneously implanted colorectal cancer cells in a TLR-dependent manner (Huang et al., 2007) . Finally, TLR expression by colorectal tumor cells may facilitate evasion from immune surveillance in a mouse model of subcutaneous tumor xenograft (Huang et al., 2005) . Taken together, TLR signaling in gastrointestinal tumor cells may be associated with subversion of host defense and progression of cancers. Because the density and diversity of commensal bacteria as well as the expression and function of TLRs differs throughout the gastrointestinal tract, the contribution of TLR signaling to carcinogenesis may differ according to location.
The upper gastrointestinal tract
In the esophagus, adenocarcinoma occurs in the setting of Barrett's esophagus in which the lining squamous epithelium is replaced by small intestinal epithelium, a process termed intestinal metaplasia (Drewitz et al., 1997) . The reason for intestinal metaplasia appears to be chronic reflux of gastric (generally acidic) contents into the lower esophagus (Fass et al., 2001) . The process leading to intestinal metaplasia may be associated with chronic inflammation (Atherfold and Jankowski, 2006) . The relationship between inflammation and tumorigenesis in esophageal adenocarcinoma remains controversial and it is fair to say that innate immune mechanisms have not been implicated thus far. It is also unclear whether the esophageal mucosa is normally exposed to bacterial antigens for protracted periods of time. Because of its motility, bacteria from the oral cavity and oropharynx may transit quickly and be destroyed by the gastric acid in the stomach. Exposure of the esophagus to PAMPs and bacteria has not been well studied.
The discovery of H. pylori in association with gastric cancer is the most direct proof that bacterial signaling and the response of the host can result in carcinogenesis (Peter and Beglinger, 2007) . Inflammation is clearly a risk factor for the development of gastric cancer in response to H. pylori. A great deal of work has been done to identify bacterial factors important in H. pylori Figure 2 Model of TLR4-mediated Cox-2 regulation (Fukata et al., 2006) . In the setting of intestinal injury, LPS exposure of intestinal epithelial cells (possibly basolaterally) and lamina propria macrophages results in TLR4 activation and signaling via MyD88. This activates a variety of signaling pathways culminating in transcription factor translocation and engagement of the Cox-2 promoter. Cox-2 is transcribed and translated; it acts on arachidonic acid to generate PGG 2 which is rapidly converted to PGH 2 and then microsomal PG E synthase-1 converts it to PGE 2 . PGE 2 through its receptors EP2 or EP4 can activate downstream signaling molecules such as the tyrosine kinase SRC or the lipid kinase PI3K which can lead to transactivation of the EGF receptor (EGFR). EGFR signaling is associated with proliferation and protection against apoptosis in intestinal epithelial cells. PGE 2 produced by macrophages may also act in trans on intestinal epithelial cells. In the absence of TLR4 signaling, Cox-2 expression is greatly decreased. TLR, Tolllike receptor; Cox-2, cyclooxygenase-2; PGE 2 , prostaglandin E 2 ; LPS, lipopolysaccharide; IKK, IkB kinase; NF-kB, nuclear factor-kB; cAMP, cyclic AMP; EGFR, EGF receptor; PGG, prostaglandin G; PGH, prostaglandin H; TRAF6, TNF receptor-associated factor-6; TAK1, transforming growth factor kinase-1.
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M Fukata and MT Abreu pathogenesis. Of these, expression of the cytotoxinassociated gene A protein is thought to confer the greatest oncogenic risk. On the host side, TLR signaling may be quite important in H. pylori-associated gastric cancer. Chronic infection with H. pylori increases TLR4 and MD-2 expression in gastric epithelial cells, and recognition of H. pylori LPS augments nuclear factor-kB (NF-kB) activation (Kawahara et al., 2001b; Ishihara et al., 2004; Schmausser et al., 2005) . TLR4 is expressed at the apical and the basolateral pole of the normal gastric epithelial cells and in H. pylori gastritis, but the expression pattern appears to change to a diffuse and homogenous distribution within the cytoplasm accompanying cellular transformation to cancer (Schmausser et al., 2005) . This alteration in expression can already be found during the stage of intestinal metaplasia in H. pylori-infected subjects (Schmausser et al., 2005) . Another study by the same authors has demonstrated that TLR4 is strongly expressed by tumor cells of H. pyloriassociated gastric carcinoma (Schmausser et al., 2005) . We have described that TLR4 signaling regulates colonic Cox-2 expression and PGE 2 production (Fukata et al., 2006) . Therefore, it is possible that the increased expression of Cox-2 and PGE 2 seen in gastric cancer of H. pylori-infected subjects may be related to TLR4 signaling in gastric epithelial cells (Romano et al., 1998; Sawaoka et al., 1998; Sung et al., 2000; Pomorski et al., 2001; Fukumoto et al., 2003) . At this stage, the connection in the stomach between TLR4 and Cox-2 induction is speculative but highly likely. In deed, H. pylori LPS induces Cox-2 expression along with nuclear translocation of NF-kB p56 in the isolated guinea pig gastric epithelial cells (Kawahara et al., 2001a) . In addition, other TLR signaling molecules, for example, TLR2 and TLR9, have also been implicated in the upregulation of Cox-2 through activation of Src and NF-kB in H. pylori-infected mucosa (Chang et al., 2004) .
Other inflammatory pathways lying downstream of pattern recognition receptors may play a role in H. pylori carcinogenesis. For example, H. pylori induces interleukin (IL)-8 secretion in a TLR2-dependent manner (Fischer et al., 2001; Mandell et al., 2004) . In addition, cytotoxin-associated gene A may enhance TLR2 signaling, because cytotoxin-associated gene A-positive H. pylori induces higher IL-8 secretion than cytotoxin-associated gene A-negative H. pylori in TLR2-and CD14-expressing HEK293 cells (Mandell et al., 2004) .
In addition to the TLRs, a study has found that nucleotide-binding oligomerization domain containing (Nod)1 senses the peptidoglycan of H. pylori and induces NF-kB-dependent IL-8 production (Viala et al., 2004) . In fact, a significant increase in the bacterial load of H. pylori has been found in Nod1-deficient mice at 7 and 30 days after inoculation compared to wild-type mice (Viala et al., 2004) . In Nod1-deficient mice, primary gastric epithelial cells produce lower amounts of the chemokine MIP-2 than wild-type mice in response to H. pylori challenge. Along the same lines, infection of MyD88-deficient mice with H. pylori has shown increased colonization and reduced mucosal inflammation and pro-inflammatory cytokine production in the stomach compared to wild-type mice (Rad et al., 2007) . Therefore, TLR and Nod signaling may modulate the inflammatory effect of H. pylori and possibly influence development of gastric cancer.
In addition to adenocarcinoma of the stomach, H. pylori infection has been linked to the development of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach. Although, the role of TLRs in the pathogenesis of MALT lymphoma has not yet been examined, the immune response to chronic antigenic stimulation by H. pylori infection is thought to induce NF-kB activation, resulting in the development of gastric MALT lymphoma (Wyatt and Rathbone, 1988; Stolte and Eidt, 1989; Farinha and Gascoyne, 2005) . Recent data demonstrate that presentation of H. pylori by dendritic cells directs adaptive immune responses and requires MyD88-dependent signaling, since MyD88-deficient dendritic cells are profoundly impaired in this process (Rad et al., 2007) . Thus, activation of TLR signaling by H. pylori may also be involved in the pathogenesis of MALT lymphoma.
The role of polymorphisms in TLRs has been addressed. First, patients with poorly differentiated gastric adenocarcinomas are more likely to carry the germ-line Thr135Ala polymorphism in the leucine-rich repeat region of TLR4 (Ohara et al., 2006) . This Thr135Ala polymorphism is present regardless of H. pylori association. TLR4 polymorphisms Asp299Gly may increase the risk of non-cardiac (The cardia region of the stomach refers to the upper part of the stomach nearest the esophagus. Cancers of this region are rising but tend to occur in H. pylori negative individuals; Spechler, 1999) gastric cancer (Hold et al., 2007) . In this study, 17% of Polish patients with gastric cancer had one or two TLR4 variant alleles vs 8% of control subjects (odds ratio ¼ 2.5, 95% confidence interval, 1.6-4.0). Similarly, 15% of non-cardiac gastric cancer cases from a US multi-center study carried at least one copy of the variant TLR4 allele, compared with only 8% of the control population (odds ratio ¼ 2.1, 95% confidence interval, 1.1-4.2) (Gammon et al., 1997; Hold et al., 2007) . Unfortunately, these studies did not address the H. pylori association, but the type of gastric cancers considered in these studies is more frequent with H. pylori. Therefore, TLR signaling both at a genetic level and genomic level may be involved in the development of gastric cancer.
The small intestine
The small intestine has a very low incidence of malignancy and represents less than 5% of all malignancies in the gastrointestinal tract (Kelly and Bartram, 1993; Haselkorn et al., 2005) . Most small intestinal cancers arise from Crohn's disease (Sigel et al., 1999) . Because innate immune abnormalities are a central factor in the pathogenesis of Crohn's disease, TLR signaling may be involved in Crohn's disease-associated small intestinal cancer. At the present time, TLRs have not been examined in small bowel cancers.
The large intestine
The genetic mutations that occur in sporadic colorectal cancer have been well studied (Konishi et al., 1996; Frattini et al., 2004; Contasta et al., 2006) . The sequence of gene mutations culminating in colon cancer has been elucidated by the work of Vogelstein and Kissler and others. In spite of the genetic model, chronic inflammation also plays a role in colorectal carcinogenesis. Epidemiologic studies demonstrate that increased C-reactive protein, a biomarker of inflammation, is associated with colon cancer and poor survival (Greten et al., 2004; Tlaskalova-Hogenova et al., 2004; Hope et al., 2005; Helzlsouer et al., 2006) . Polymorphisms in cytokine genes, in particular IL-1 and IL-8, are associated with an increased risk of adenomatous polyps or cancer development (Gunter et al., 2006) . An elevated serum concentration of IL-6 has correlated with a higher tumor stage and worse prognosis of colorectal cancer (Kinoshita et al., 1999; De Vita et al., 2001; Chung and Chang, 2003) . These results suggest that inflammation can be an initiator as well as a promoter in colorectal carcinogenesis.
How can innate immune signaling be involved in sporadic colorectal carcinogenesis? The hypothesis that intestinal bacteria might play a key role in colorectal cancerogenesis dates back to 1971 (Hill et al., 1971) . High concentrations of bacteria have been detected in biopsy specimens of 90% of colorectal cancers and 93% of adenomas in the large intestine, whereas no bacteria were found in the colonic mucosa of normal controls (Swidsinski et al., 1998) . Several possibilities including carcinogenic bacterial enzymes and generation of reactive oxygen intermediates link intestinal bacteria to the development of colorectal cancer (Hope et al., 2005; Manju and Nalini, 2006) . Recent data demonstrate that Enterococcus faecalis, a common gut commensal, can induce chromosomal instability through superoxide production (Wang and Huycke, 2007) .
Recent advances in innate immunity may illuminate the mechanism underlying inflammation-induced colorectal carcinogenesis. A small Croatian study has shown that patients with colorectal cancer are more likely to carry a microsatellite GT polymorphism in the TLR2 gene as well as the Asp299Gly allele of the TLR4 gene (Boraska Jelavic et al., 2006) . Blocking TLR4 signaling in colon cancer cells results in a reduction of tumor growth in a subcutaneously implanted mouse model (Huang et al., 2005) . These results suggest that bacterial recognition system especially by TLRs may have a significant role in tumor progression.
More recently, involvement of TLR signaling through the adaptor molecule MyD88 in tumor growth and progression has been reported in Apc
Min/ þ mice model (Rakoff-Nahoum and Medzhitov, 2007) . These mice carry a germ-line mutation in the tumor suppressor Apc gene, which is frequently mutated in sporadic and hereditary forms of human colorectal cancer. Apc Min/ þ mice spontaneously develop multiple adenomas through gastrointestinal tract, especially the small intestine (Powell et al., 1992; Su et al., 1992) . Although the overall incidence of intestinal tumors was similar to control Apc Min/ þ mice, MyD88 deficiency in Apc
Min/ þ mice resulted in a significant decrease in visible tumors in the small and large intestine (Rakoff-Nahoum and Medzhitov, 2007). MyD88-deficient Â Apc Min/ þ mice demonstrated decreased expression of several growth modifier genes, including Cox-2 in the tumor tissue as compared to Apc Min/ þ mice. The exact mechanism underlying MyD88-dependent tumorigenesis remains unclear. In particular, these results do not necessarily point to TLR-dependent signaling or to a role for small bowel bacteria since both are low under normal conditions (Abreu et al., 2001; Melmed et al., 2003) .
Since the Apc
Min/ þ mice demonstrate a lower incidence of tumor development in the germ-free state, there may be a role of TLR signaling in response to commensal bacteria in intestinal tumorigenesis (Dove et al., 1997) .
Patients with IBD are at an increased risk of developing colorectal cancer (Ekbom et al., 1990; Langholz et al., 1992; Choi and Zelig, 1994) . The risk of colorectal cancer in patients with IBD increases by 0.5-1.0% yearly beginning 8-10 years after diagnosis (Gyde et al., 1988; Eaden et al., 2001; Itzkowitz and Harpaz, 2004) . Unlike sporadic colon cancers in which APC mutations occur early, APC mutations tend to be a late event. Recent data demonstrate that the severity of inflammation correlates with the risk of colitisassociated cancer (CAC) (Rutter et al., 2004; Gupta et al., 2007) . Although the exact cause of the inflammation in IBD is still unknown, abnormal immune responses to luminal bacteria plays a crucial role in the pathogenesis of IBD. Mounting evidence supports a role for deranged innate immune abnormalities in IBD. Several polymorphisms associated with innate immune receptors have been reported as candidate genes in IBD. The first gene discovered associated with disease susceptibility in Crohn's disease, NOD2/CARD15, encodes a protein that acts as an intracellular pattern recognition receptors for muramyl dipeptide (Hugot et al., 2001; Chamaillard et al., 2003) . The Asp299Gly polymorphism of TLR4 is associated with both ulcerative colitis and Crohn's disease (Franchimont et al., 2004; Torok et al., 2004b; Brand et al., 2005; Gazouli et al., 2005; Oostenbrug et al., 2005; Ouburg et al., 2005) . Crohn's disease has been associated with a TLR9 polymorphism, which is interesting given the animal data that TLR9 may be anti-inflammatory in certain contexts (Torok et al., 2004a) . SNPs in TLR1, -2 and -6 have been examined in IBD. Although none of the SNPs was involved in disease susceptibility, all were associated with more colonic disease extent in ulcerative colitis and Crohn's disease (Pierik et al., 2006) . Although these polymorphisms have not yet been associated with development of CAC, genotype-phenotype associations suggest a link between TLR polymorphisms and CAC. For instance, TLR1 R80T and TLR2 R753G SNP were associated with pancolitis in ulcerative colitis, and pancolitis is one of the risk factors for CAC (Itzkowitz and Harpaz, 2004; Pierik et al., 2006) .
Several rodent models of CAC require commensal bacteria or specific bacteria (H. hepaticus) for initiation of colitis and development of dysplasia or cancer, suggesting an essential role for commensal bacteria in CAC (Sellon et al., 1998; Itzkowitz and Yio, 2004; Maggio-Price et al., 2005) . Mice deficient in IL-2, IL-10, double knockouts for the T-cell receptor and p53 or tumor growth factor b1 and recombination activating gene 2 develop adenocarcinoma in the small and large intestine. In the absence of bacteria, these mouse models neither develop inflammation nor dysplasia or cancer (Sellon et al., 1998; Schultz et al., 1999; Kado et al., 2001; Engle et al., 2002) . Given that H. hepaticus infection induces CAC in recombination activating gene 2-deficient mice, these data support the premise that innate immune responses to commensal bacteria are sufficient to induce inflammation-associated gastrointestinal carcinogenesis (Erdman et al., 2003) .
The other type of animal model of CAC uses a chemically induced colitis. Azoxymethane (AOM) is a colonic genotoxic carcinogen that has been extensively used in the investigation of colorectal carcinogenesis and enhances the incidence of dysplastic lesions in response to DSS-induced murine colitis (Suzuki et al., 2005 Paulsen et al., 2006) . As with the genetic models of CAC, germ-free rats given AOM are protected from colonic dysplasia and cancer, suggesting a role of commensal bacteria in the chemically induced CAC model (Reddy et al., 1975; Laqueur et al., 1981) . AOM intercalates in the DNA but reactive oxygen or nitrogen species resulting in oxidative DNA damage are necessary to induce dysplasia in C57BL/6 mice (Rao et al., 2002; Derdak et al., 2006) . TLR4 signaling may directly lead to the production of ROS/RONS (Ishida et al., 2002; Asehnoune et al., 2004; Park et al., 2004; Matsuzawa et al., 2005) . To the extent that TLR4 signaling is necessary for neutrophil recruitment to the intestine , and TLR4 is indirectly responsible for ROS generation as well. ROS may also be intermediaries in TLR4-dependent activation of NF-kB (Asehnoune et al., 2004) . Furthermore, we have currently described that TLR4-deficient mice exhibit a significantly decreased incidence and size of colorectal tumors in the AOM-DSS model compared to wild-type mice (Fukata et al., 2007) . Mechanistically, we have shown that upregulation of mucosal Cox-2 and amphiregulin expression downstream of TLR4 results in epidermal growth factor receptor phosphorylation and cell proliferation (Figure 3 ) (Fukata et al., 2006 (Fukata et al., , 2007 .
Given our results in a CAC model, TLR signaling is clearly involved in the development of CAC. However, several TLR-expressing cell types may contribute to the Figure 3 Model of TLR4-mediated colon carcinogenesis (Fukata et al., 2007) . TLR4 expression is increased in chronic intestinal inflammation. TLR4 signaling in response to LPS induces Cox-2 expression and PGE 2 production. PGE 2 through its receptors can act in a paracrine or autocrine fashion on colonocytes to stimulate the expression and release of amphiregulin, an EGFR ligand. EGFR signaling is associated with increased proliferation of colonocytes. Likewise, TLR4 expression in tumor-associated macrophages may also respond to LPS by inducing Cox-2 and PGE 2 , which may then act on the epithelium to stimulate proliferation of colonocytes. TLR, Toll-like receptor; LPS, lipopolysaccharide; Cox-2, cyclooxygenase-2; PGE 2 , prostaglandin E 2 .
Role of TLRs in gastrointestinal malignancies M Fukata and MT Abreu development of dysplasia or cancer. We have shown TLR signaling regulates Cox-2 expression in both IEC and lamina propria macrophages in the setting of colitis (Fukata et al., , 2006 . Importantly, Cox-2 expression by macrophages infiltrated inside of the tumor has been thought to be an early event in colorectal carcinogenesis (Janne and Mayer, 2000) . Karin and coworkers have generated mice with a conditional ablation of IkB kinase-b in either IEC or myeloid cells and examined their effect on the development of CAC in the AOM-DSS model (Greten et al., 2004) . The deletion of IkB kinase-b in IEC results in a dramatic reduction in the number of adenomas, whereas deletion of IkB kinase-b in myeloid cells has a modest effect on adenoma numbers but a greater effect on adenoma size. More importantly, deletion of IkB kinase-b in IEC has no effect on the underlying inflammation. These data suggest that NF-kB may have differential roles in inflammation and carcinogenesis, and these effects may be cell autonomous or through cell-cell interactions.
Given that an important end point of TLR signaling is NF-kB activation, TLRs may provide the input to NF-kB resulting in malignancy. The single immunoglobulin IL-1 receptor-related molecule acts as a negative regulator of TLR signaling. Single immunoglobulin IL-1 receptor-related moleculeÀ/À animals demonstrate significantly greater inflammation and increased tumorigenesis following treatment with AOM-DSS (Garlanda et al., 2007; Xiao et al., 2007) . Restitution of single immunoglobulin IL-1 receptor-related molecule expression in the epithelium reduces tumors, suggesting a role for epithelial TLR signaling in tumor development.
Concluding remarks
Currently, safe and effective chemopreventive strategies for gastrointestinal malignancies are lacking. While Cox-2 inhibitors offered great promise for patients with previous adenomas, trials were discontinued due to the increase in thrombotic events (Arber et al., 2006; Bertagnolli et al., 2006) . The prevalence of H. pylori infection is decreasing in the Western world but the incidence of inflammation-related gastric cancer remains high in the developing world. For patients with IBD, treatment has dramatically improved in the last 10 years. 5-Aminosalicylates have a modest chemopreventive benefit but some studies have not found any benefit (Bernstein et al., 2002) . Targeted inhibition of specific TLR pathways may provide an effective strategy in preventing development of selected gastrointestinal malignancies. Because the gastrointestinal tract can be accessed without the need for systemic delivery, TLR antagonists may be developed to interrupt oncogenic pathways and delivered locally. Lastly, combination approaches may maximize the benefits of treatment while minimizing toxicity of individual compounds.
